Korean J Med.  2010 Jul;79(1):72-76.

A case of Castleman's disease patient treated successfully with cyclic high-dose steroid therapy

Affiliations
  • 1Department of Internal Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea. hosukoh@hanmail.net
  • 2Department of Pathology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.

Abstract

Castleman's disease is rare, and its cause is unknown. Although various treatments have been attempted, no standard treatment has been established for it. A 51-year-old male on hemodialysis with end-stage renal disease was admitted to our hospital with fever and myalgia. He was diagnosed with multicentric Castleman's disease (MCD) of the hyaline vascular type. Considering his underlying disease and general condition, cyclic high-dose steroid therapy (prednisolone 1 mg/kg/day for 5 days) was administered every 4 weeks, eight times in total. After this, no symptomatic manifestations of MCD or signs on computed tomography were observed. We report an immunocompromised patient diagnosed with MCD of the hyaline vascular type, who was successfully treated with cyclic high-dose steroid therapy.

Keyword

Castleman's disease; Lymphoproliferative disorder; ESRD; Prednisolone

MeSH Terms

Corneal Dystrophies, Hereditary
Fever
Giant Lymph Node Hyperplasia
Humans
Hyalin
Immunocompromised Host
Kidney Failure, Chronic
Lymphoproliferative Disorders
Male
Middle Aged
Prednisolone
Renal Dialysis
Corneal Dystrophies, Hereditary
Giant Lymph Node Hyperplasia
Prednisolone
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr